Evidence map›Paper›PMID 26348142›Full record

ArticleActa biomaterialia2015

Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix.

Kuan-Chih Kuo, Ruei-Zeng Lin, Han-Wen Tien, Pei-Yun Wu, Yen-Cheng Li, Juan M Melero-Martin, Ying-Chieh Chen

Abstract read
In one paragraph

Article in Acta biomaterialia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. A review of advanced hydrogels for cartilage tissue engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.Frontiers in bioengineering and biotechnology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kuan-Chih KuoDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Ruei-Zeng LinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Han-Wen TienDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Pei-Yun WuDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC.
Yen-Cheng LiMaterial and Chemical Research Laboratories, Industrial Technology Research Institute, Hsinchu 31040, Taiwan, ROC.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ying-Chieh ChenDepartment of Applied Science, National Hsinchu University of Education, Hsinchu 30014, Taiwan, ROC. Electronic address: yingchiehchen@gmail.com.
National Hsinchu University of Education · TWHarvard University · USIndustrial Technology Research Institute · TW

Funding

Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Engineering vascularized tissue in vivo using postnatal progenitor cellsR00EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2011 to 2013
$719k
Engineering vascularized tissue in vivo using postnatal progenitor cellsK99EB009096 · NIBIB · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2009 to 2010
$180k
NHLBI NIH HHS R01 HL128452NIBIB NIH HHS K99 EB009096NIBIB NIH HHS R00 EB009096NIBIB NIH HHS R00EB009096
6 · The paper itself

Abstract

Tissue engineering promises to restore or replace diseased or damaged tissue by creating functional and transplantable artificial tissues. The development of artificial tissues with large dimensions that exceed the diffusion limitation will require nutrients and oxygen to be delivered via perfusion instead of diffusion alone over a short time period. One approach to perfusion is to vascularize engineered tissues, creating a de novo three-dimensional (3D) microvascular network within the tissue construct. This significantly shortens the time of in vivo anastomosis, perfusion and graft integration with the host. In this study, we aimed to develop injectable allogeneic collagen-phenolic hydroxyl (collagen-Ph) hydrogels that are capable of controlling a wide range of physicochemical properties, including stiffness, water absorption and degradability. We tested whether collagen-Ph hydrogels could support the formation of vascularized engineered tissue graft by human blood-derived endothelial colony-forming cells (ECFCs) and bone marrow-derived mesenchymal stem cells (MSC) in vivo. First, we studied the growth of adherent ECFCs and MSCs on or in the hydrogels. To examine the potential formation of functional vascular networks in vivo, a liquid pre-polymer solution of collagen-Ph containing human ECFCs and MSCs, horseradish peroxidase and hydrogen peroxide was injected into the subcutaneous space or abdominal muscle defect of an immunodeficient mouse before gelation, to form a 3D cell-laden polymerized construct. These results showed that extensive human ECFC-lined vascular networks can be generated within 7 days, the engineered vascular density inside collagen-Ph hydrogel constructs can be manipulated through refinable mechanical properties and proteolytic degradability, and these networks can form functional anastomoses with the existing vasculature to further support the survival of host muscle tissues. Finally, optimized conditions of the cell-laden collagen-Ph hydrogel resulted in not only improving the long-term differentiation of transplanted MSCs into mineralized osteoblasts, but the collagen-Ph hydrogel also improved an increased of adipocytes within the vascularized bioengineered tissue in a mouse after 1 month of implantation. STATEMENT OF SIGNIFICANCE: We reported a method for preparing autologous extracellular matrix scaffolds, murine collagen-Ph hydrogels, and demonstrated its suitability for use in supporting human progenitor cell-based formation of 3D vascular networks in vitro and in vivo. Results showed extensive human vascular networks can be generated within 7 days, engineered vascular density inside collagen-Ph constructs can be manipulated through refinable mechanical properties and proteolytic degradability, and these networks can form functional anastomoses with existing vasculature to further support the survival of host muscle tissues. Moreover, optimized conditions of cell-laden collagen-Ph hydrogel resulted in not only improving the long-term differentiation of transplanted MSCs into mineralized osteoblasts, but the collagen-Ph hydrogel also improved an increased of adipocytes within the vascularized bioengineered tissue in a mouse.

Indexed as

Acellular DermisAnimalsBioartificial OrgansBlood VesselsCollagenCross-Linking ReagentsEndothelial CellsEquipment Failure AnalysisExtracellular MatrixHorseradish PeroxidaseHydrogelsInjectionsMaleMesenchymal Stem Cell TransplantationMiceMice, Inbred BALB CCollagenCross-Linking ReagentsHorseradish PeroxidaseHydrogelsCollagen hydrogelsTissue engineeringVascularization

Identifiers

PMID26348142
PMCPMC4624458
OpenAlexW2235448797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.